Natalia Borruel

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Translation and Spanish validation of the Quality of Life Questionnaire for patients with perianal fistula in Crohn's disease (Sp CAF-QoL Scale).

Translation and Spanish validation of the Quality of Life Questionnaire for patients with perianal fistula in Crohn's disease (Sp CAF-QoL Scale).

Journal: Revista espanola de enfermedades digestivas

Published: July 21, 2026

Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis.

Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis.

Journal: Gut

Published: November 04, 2025

Fecal microbiome of patients with ulcerative colitis reflects their phenotype and inflammatory level.

Fecal microbiome of patients with ulcerative colitis reflects their phenotype and inflammatory level.

Journal: Scientific reports

Published: November 03, 2025

Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients.

Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients.

Journal: Cells

Published: June 22, 2025

Higher ustekinumab concentrations in induction are associated with better endoscopic outcomes in inflammatory bowel disease.

Higher ustekinumab concentrations in induction are associated with better endoscopic outcomes in inflammatory bowel disease.

Journal: Therapeutic advances in gastroenterology

Published: April 11, 2025

Novel Approaches to Treatment of Immune-Mediated Chronic Intestinal Pseudo-Obstruction.

Novel Approaches to Treatment of Immune-Mediated Chronic Intestinal Pseudo-Obstruction.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 05, 2025

Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.

Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.

Journal: Biomarker research

Published: February 04, 2025

Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study.

Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study.

Journal: Crohn's & colitis 360

Published: October 18, 2024

Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.

Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.

Journal: Gastroenterologia y hepatologia

Published: July 12, 2024

A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process.

A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process.

Journal: Journal of Crohn's & colitis

Published: July 13, 2023

Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital.

Severe and refractory gastrointestinal toxicity due to immune checkpoint inhibitors: clinical experience in a tertiary referral hospital.

Journal: Revista espanola de enfermedades digestivas

Published: May 12, 2023

JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases.

JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseases.

Journal: Frontiers in medicine

Published: November 03, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026